Characterization of bone mineral density (BMD) at the time of diagnosis in postmenopausal patients with operable breast cancer: Association with clinical-pathological findings

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 9611-9611 ◽  
Author(s):  
K. Altundag ◽  
E. Kim ◽  
K. Broglio ◽  
A. U. Buzdar ◽  
G. N. Hortobagyi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Bone Mineral ◽  
Operable Breast Cancer ◽  
Pathological Findings ◽  
Mineral Density

Evaluation with densitometry of patients with breast cancer and low bone mineral density after 2 years of treatment

2013 ◽  
Author(s):  
Sonia Munoz Gil ◽  
Tomas Mut Dolera ◽  
Belen C Garrido Lopez ◽  
M D Torregrosa Maicas ◽  
R Girones Sarrio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Bone Mineral ◽  
Mineral Density ◽  
Low Bone Mineral Density

Effects of One-Year Adjuvant Treatment with Tamoxifen on Bone Mineral Density in Postmenopausal Breast Cancer Women

1996 ◽  
Vol 82 (1) ◽  
pp. 65-67 ◽  
Author(s):  
Sandro Barni ◽  
Paolo Lissoni ◽  
Gabriele Tancini ◽  
Antonio Ardizzoia ◽  
Marina Cazzaniga
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Alkaline Phosphatase ◽  
Bone Mineral Content ◽  
Bone Mineral ◽  
Adjuvant Treatment ◽  
Mineral Content ◽  
Postmenopausal Breast Cancer ◽  
Mineral Density ◽  
One Year

In this study, the authors have analyzed the possible effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women. Bone mineral content was studied by photon absorptiometry (I-125), whereas bone balance was analyzed indirectly by serum PTH, osteocalcin, calcitonin, calcium and alkaline phosphatase levels. Bone mineral content and serum bone-related substances were measured before starting treatment and after one year. Results were analyzed using Student's t test for paired data. No difference was found between the two measurements for bone mineral content, PTH, calcitonin, calcium and alkaline phosphatase levels. Measurements at entry and after one year of treatment showed a statistically significant difference ( P < 0.001) only for osteocalcin. In accordance with other authors, we can conclude that treatment with tamoxifen does not cause an increase in menopausal bone resorption. The finding that osteocalcin levels decreased after one year of therapy with tamoxifen is interesting, but further studies are necessary to clarify the role of such levels in predicting a turnover of bone balance towards osteoblastic activity.

Bone mineral density in Brazilian Midwest women recently diagnosed with breast cancer: A case-control study

2018 ◽  
Vol 92 ◽  
pp. S50
Author(s):  
R. De Freitas Junior ◽  
L.V. Gonçalves ◽  
R.M. Schingaglia ◽  
J. Godinho-Mota ◽  
K.A. Martins ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Bone Mineral ◽  
Case Control Study ◽  
Case Control ◽  
Mineral Density ◽  
Control Study

scholarly journals Relationship of Bone mineral density and the risk of breast cancer in Korean postmenopausal women

2006 ◽  
Vol 9 (4) ◽  
pp. 330 ◽  
Author(s):  
Hee Jeong Kim ◽  
Jung man Nam-Gung ◽  
Jung Min Koh ◽  
Jung sun Lee ◽  
Soo jeong Hong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Mineral Density ◽  
Relationship Of

Bone mineral density and risk of breast cancer in postmenopausal women

2013 ◽  
Vol 138 (1) ◽  
pp. 261-271 ◽  
Author(s):  
Xinhua Qu ◽  
Xiaoyu Zhang ◽  
An Qin ◽  
Guangwang Liu ◽  
Zanjing Zhai ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Mineral Density
Sign in / Sign up

Export Citation Format

Share Document